InMed Pharmaceuticals, Inc.

Ordinary Shares International Reporting
Verified Company Profile 7/21/2016
Contact Info
  • 350-409 Granville Street
  • Vancouver, BC V6C1T2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2016 Annual Report
CIK 0001429816
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Eric Adams President
Terese Gieselman CFO
Sazzad Hossain Chief Scientific Officer
Company Directors
Chris Bogart
Adam Cutler
William Garner
Sazzad Hossain
Andrew Hull
Craig Schneider
Company Notes
  • Formerly=Cannabis Technologies Inc. until 10-2014
  • Formerly=Meridex Software Corp. until 5-2014
  • Formerly=Meridex Network Corp. until 2-03
Service Providers
Accounting/Auditing Firm
Anton & Chia LLP
3027 Townsgate Road
Westlake Village, CA, 91361
United States

Legal Counsel
Stella Business Law Services
3691 West King Edward Avenue
Vancouver, BC, V6S 1M8

Investor Relations Firm
Not Available
IMLFF Security Details
Share Structure
Market Value1 $8,998,108 a/o Oct 21, 2016
Authorized Shares Unlimited a/o Jul 20, 2016
Outstanding Shares 69,216,217 a/o Jul 20, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Shareholders of Record Not Available
Non US Stock Exchange Listing
IN - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 3,643 (-84.25%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security